This is a preview of subscription content, log in via an institution to check access.
References
De Paulis A, Cirillo R, Ciccarelli A, et al.: FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon R1 + cells. J Immunol 1991, 146:2374–2381.
Grattan Ce, O’Donnell BF, Francis DM, et al.: Randomized double blind study of cyclosporine in chronic “idiopathic” urticaria. Br J Dermatol 2000, 143:365–372.
Marsland AM, Soundararajan S, Joseph K, Kaplan AP:Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005, 35:554–559.
Boehm I, Bauer R, Bieber T: Urticaria treated with dapsone. Allergy 1999, 54:765–770.
Berry MA, Hargadon B, Shelley M, et al.: Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006, 354:697–708.
Wright RC: Atopic dermatitis-like eruption precipitated by infiiximab. J Am Acad Dermatol 2004, 1:259–272.
Chan JL, Davis-Reed L, Kimball AB: Counter-regulatory balance: Atopic dermatitis in patients undergoing infiiximab infusion therapy. J Drugs Dermatol 2004, 3:315–318.
Rights and permissions
About this article
Cite this article
Bingham, C.O. Allergic dermatosis and urticaria. Curr Allergy Asthma Rep 6, 261–264 (2006). https://doi.org/10.1007/s11882-006-0057-9
Issue Date:
DOI: https://doi.org/10.1007/s11882-006-0057-9